HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Sebastian A. Defranchi Stephen D. Cassivi Francis C. Nichols Mark S. Allen Claude Deschamps Dennis A. Wigle Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Defranchi, S. A. Articles by Wigle, D. A. Search for Related Content PubMed PubMed Citation Articles by Defranchi, S. A. Articles by Wigle, D. A. Related Collections Lung - cancer Related Article

---

Original Articles: General Thoracic

N2 Disease in T1 Non-Small Cell Lung Cancer

Division of General Thoracic Surgery, Mayo Clinic, Rochester, Minnesota

Accepted for publication May 13, 2009.

^_* Address correspondence to Dr Wigle, Division of General Thoracic Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Email: wigle.dennis{at}mayo.edu).

Presented at the Poster Session of the Forty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Francisco, CA, Jan 26–28, 2009. Winner of the Blue Ribbon as the top General Thoracic Poster.

Background: The optimal management strategy for mediastinal staging in early-stage non-small cell lung cancer (NSCLC) is not clearly defined. The true prevalence of mediastinal lymph node metastases (N2 disease) in resected pathologic T1 (pT1) NSCLC must be known to define the role of invasive mediastinal staging in these patients.

Methods: Data of patients with pT1 lesions resected at Mayo Clinic between 1998 and 2006 were retrospectively reviewed. Patients with N2 disease were identified from pathology and operative reports. We reviewed demographics, radiologic data, and surgical procedures for those with pathologic T1 N2 NSCLC.

Results: We identified 968 cases of pT1 lesions, 59 with pN2 disease (6.1%). For those with T1 N2 disease, the primary lung lesion was peripheral in 18 (31%) and central in 41 (69%). Of these, 36 had negative non-invasive mediastinal staging (3.7%) and were incidentally discovered. The most frequently affected lymph node station was 7 in 22 patients (37%), followed by 5,6 in 18 (31%). Mediastinoscopy found positive lymph nodes in 3 of 16 patients (19%) in which it was performed. Overall 5-year survival for pT1 N2 incidentally discovered during mediastinal lymph node dissection at the time of lung resection was 46% (95% confidence interval, 31% to 68%).

Conclusions: True pT1 NSCLC harbors a relatively low rate of N2 disease. The rate of occult N2 disease not observed on noninvasive preoperative mediastinal staging is even lower. For patients with T1 NSCLC and negative mediastinal imaging, routine mediastinoscopy results in a low yield of occult N2 disease discovery.

Related Article

Invited Commentary

Stephen C. Yang
Ann. Thorac. Surg. 2009 88: 928-929. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				B. H. Kirmani, R. C. Rintoul, T. Win, C. Magee, L. Magee, C. Choong, F. C. Wells, and A. S. Coonar Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer Eur J Cardiothorac Surg, January 1, 2013; 43(1): 104 - 110. [Abstract] [Full Text] [PDF]

				Y. Zhang, Y. Sun, J. Xiang, Y. Zhang, H. Hu, and H. Chen A prediction model for N2 disease in T1 non-small cell lung cancer J. Thorac. Cardiovasc. Surg., December 1, 2012; 144(6): 1360 - 1364. [Abstract] [Full Text] [PDF]

				S. A. Defranchi and D. A. Wigle Reply Ann. Thorac. Surg., October 1, 2011; 92(4): 1551 - 1552. [Full Text] [PDF]

				S. C. Yang Invited Commentary Ann. Thorac. Surg., September 1, 2009; 88(3): 928 - 929. [Full Text] [PDF]